مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

268
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

157
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

COMPARISON OF DIFFERENT DOSES OF SUBCONJUNCTIVAL SUNITINIB WITH BEVACIZUMAB IN THE TREATMENT OF CORNEAL NEOVASCULARIZATION IN EXPERIMENTAL RATS

Pages

  0-0

Abstract

 Background: To compare the efficacy of SUBCONJUNCTIVAL administration of BEVACIZUMAB and different doses of SUNITINIB malate in reducing CORNEAL NEOVASCULARIZATION (CNV). Materials and Methods: In this experimental study, central corneal cauterization was created in the right eye of fifty male Sprague–Dawley RATs. On day 1 (1 week after cauterization), RATs were randomly assigned into five treatment groups. Group control (n=10) received SUBCONJUNCTIVAL injection of 0.02 ml of base saline solution. Group 1 (n=10) received 0.02 ml of BEVACIZUMAB (25 mg/ml). Group 2, 3, and 4 (n=10 for each group) were treated with 0.02 ml of SUNITINIB malate (10, 20, and 50 μg/ml, respectively). On days 1, 7, and 14, digital photographs of the cornea were taken, and the area of CNV was measured.Results: During the 2-week follow-up, CNV area in treatment groups was less than in control group (P<0.05). On day 7, corneal avascular area was highest in Group 3 at 63%. On day 14, the area of CNV in Groups 2 and 3 was less than in Group 1 (P=0.031 and 0.011, respectively), but the difference between Groups 2 and 3 was not statistically significant (P=0.552). The decreased CNV area on day 14 in Group 4 was significant in comparison to BEVACIZUMAB, but it was not significant on day 7 (P=0.25 on day 7 and 0.002 on day 14).Conclusion: SUBCONJUNCTIVAL SUNITINIB malate is more effective than BEVACIZUMAB in regressing CNV. This effect is more prominent on day 14.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    HASHEMIAN, MOHAMMAD NASSER, MAHRJERDI, HADI Z., MAZLOUMI, MEHDI, Safizadeh, Mona S., SHAKIBA, YADOLLAH, RAHIMI, FIROUZEH, AFARIDEH, MOHSEN, Zare, Mohamad Ali, FALLAH TAFTI, MOHAMMADREZA, Bohrani Sepidan, Bahram, ABTAHI, MOHAMMAD ALI, & ABTAHI, SEYED HOSSEIN. (2016). COMPARISON OF DIFFERENT DOSES OF SUBCONJUNCTIVAL SUNITINIB WITH BEVACIZUMAB IN THE TREATMENT OF CORNEAL NEOVASCULARIZATION IN EXPERIMENTAL RATS. JOURNAL OF RESEARCH IN MEDICAL SCIENCES (JRMS), 21(11), 0-0. SID. https://sid.ir/paper/688774/en

    Vancouver: Copy

    HASHEMIAN MOHAMMAD NASSER, MAHRJERDI HADI Z., MAZLOUMI MEHDI, Safizadeh Mona S., SHAKIBA YADOLLAH, RAHIMI FIROUZEH, AFARIDEH MOHSEN, Zare Mohamad Ali, FALLAH TAFTI MOHAMMADREZA, Bohrani Sepidan Bahram, ABTAHI MOHAMMAD ALI, ABTAHI SEYED HOSSEIN. COMPARISON OF DIFFERENT DOSES OF SUBCONJUNCTIVAL SUNITINIB WITH BEVACIZUMAB IN THE TREATMENT OF CORNEAL NEOVASCULARIZATION IN EXPERIMENTAL RATS. JOURNAL OF RESEARCH IN MEDICAL SCIENCES (JRMS)[Internet]. 2016;21(11):0-0. Available from: https://sid.ir/paper/688774/en

    IEEE: Copy

    MOHAMMAD NASSER HASHEMIAN, HADI Z. MAHRJERDI, MEHDI MAZLOUMI, Mona S. Safizadeh, YADOLLAH SHAKIBA, FIROUZEH RAHIMI, MOHSEN AFARIDEH, Mohamad Ali Zare, MOHAMMADREZA FALLAH TAFTI, Bahram Bohrani Sepidan, MOHAMMAD ALI ABTAHI, and SEYED HOSSEIN ABTAHI, “COMPARISON OF DIFFERENT DOSES OF SUBCONJUNCTIVAL SUNITINIB WITH BEVACIZUMAB IN THE TREATMENT OF CORNEAL NEOVASCULARIZATION IN EXPERIMENTAL RATS,” JOURNAL OF RESEARCH IN MEDICAL SCIENCES (JRMS), vol. 21, no. 11, pp. 0–0, 2016, [Online]. Available: https://sid.ir/paper/688774/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button